In partnership with
Easy setup, easy money
Making money from your content shouldn’t be complicated. With Google AdSense, it isn’t.
Automatic ad placement and optimization ensure the highest-paying, most relevant ads appear on your site. And it literally takes just seconds to set up.
That’s why WikiHow, the world’s most popular how-to site, keeps it simple with Google AdSense: “All you do is drop a little code on your website and Google AdSense immediately starts working.”
The TL;DR? You focus on creating. Google AdSense handles the rest.
Start earning the easy way with AdSense.
THE MONEY IDEA💡
4 Cheap Stocks for 2026
Welcome, we are {{active_subscriber_count}} Money Masters and counting!
As 2025 winds down, markets are refocusing on valuation over momentum. With the help of Morningstar’s expert research team, we reviewed the year-end’s best and worst stock calls and identified four companies that remain meaningfully undervalued heading into 2026. These are not short term rebounds, they are long term setups built around margin of safety, durable business models, and patient capital.
Cheap does not mean broken. It means opportunity for those willing to wait.
Market Mood: Selective and Value Focused 🔍
Conviction Level: ●●●●○ (4/5)
Year end resets often reward fundamentals over narratives.
Now let’s dive in↓
We have to remember that cheap can mean something is on sale.
THE MONEY IDEA💡
4 Cheap Stocks for 2026
Bottom Line: A narrow moat biotech trading at a discount with upside tied to Alzheimer’s drug adoption and pipeline optionality.
Leqembi Launch: Early Alzheimer’s uptake is tracking ahead of expectations and helping offset declines in legacy MS drugs.
Pipeline Leverage: Additional neurological and rare disease assets provide upside beyond the base case valuation.
Earnings Reset: Near term volatility masks a longer runway if new therapies scale successfully.
Valuation Gap: Shares trade at a meaningful discount despite improving fundamentals.
Risk Profile: High uncertainty means patience and position sizing matter.
Do This Next: Treat BIIB as a satellite position with long term upside rather than a short term catalyst trade.
Bottom Line: A wide moat compounder trading below fair value with both defensive characteristics and long term AI driven growth.
Platform Strength: Azure, enterprise software, and productivity tools anchor recurring revenue.
AI Monetization: Copilot and cloud based AI services add incremental growth without disrupting the core business.
Downside Cushion: Diverse revenue streams help protect earnings during economic slowdowns.
Steady Compounding: Morningstar still models attractive long term earnings growth despite a quieter 2025.
Valuation Support: Shares remain in four star territory with a solid margin of safety.
Do This Next: Use MSFT as a core portfolio anchor and add on periods of market hesitation.
Bottom Line: A wide moat wealth management platform benefiting from rising advised assets and scalable economics.
Moat Upgrade: High switching costs and advisor loyalty support durable excess returns.
Market Tailwinds: Rising asset values directly lift fee based revenue.
Interest Income: Cash sweep programs continue to support earnings while rates remain elevated.
Organic Growth: Advisor recruiting and selective acquisitions drive long term expansion.
Undervalued Setup: Shares still trade well below Morningstar’s fair value estimate.
Do This Next: Accumulate LPLA as a long term financial services compounder rather than a cyclical trade.
Bottom Line: A low cost US shale producer trading at a discount even under conservative oil price assumptions.
Cost Advantage: One of the lowest cost operators on the US shale curve.
Capital Discipline: Focus on shareholder returns over aggressive production growth.
Commodity Reset: Negative sentiment has pushed valuations below intrinsic value.
Oil Assumptions: Morningstar models value even with modest long term oil prices.
Income Potential: Variable payouts add return potential during stronger commodity periods.
Do This Next: Use DVN as selective energy exposure with a value margin rather than a directional oil bet.
MEME CORNER😁
Our Favorite Meme of the Day
That’s one way to look at it.
ACTION PLAN✅
Let’s Make Money Today!
Quick Money: Understand that the strongest portfolios are built by learning from past cycles, avoiding repeated mistakes, and consistently buying high quality businesses when they trade below intrinsic value.
$BIIB ( ▲ 0.86% ): Small position biotech value play with asymmetric upside tied to drug execution.
$MSFT ( ▲ 0.24% ): Core long term holding to add on weakness as AI monetization compounds quietly.
$LPLA ( ▼ 0.24% ): Accumulate on pullbacks for steady fee driven growth and rising advised assets.
$DVN ( ▼ 0.39% ): Add selectively for discounted energy exposure backed by cost discipline and cash flow.
If you’re looking for more smart, actionable ideas beyond this week’s picks, we’ve gathered a short list of other high-quality newsletters worth your time.
See our curated picks here — practical insights on money, work, and life from trusted sources.
Optional Deep Dive
For those looking for a longer-term framework to navigate pullbacks, rate cycles, and uncertainty, The Money Path breaks down the process step by step.
QUOTE CORNER📄
Quote of The Week
-Ayn Rand
Last Time the Market Was This Expensive, Investors Waited 14 Years to Break Even
In 1999, the S&P 500 peaked. Then it took 14 years to gradually recover by 2013.
Today? Goldman Sachs sounds crazy forecasting 3% returns for 2024 to 2034.
But we’re currently seeing the highest price for the S&P 500 compared to earnings since the dot-com boom.
So, maybe that’s why they’re not alone; Vanguard projects about 5%.
In fact, now just about everything seems priced near all time highs. Equities, gold, crypto, etc.
But billionaires have long diversified a slice of their portfolios with one asset class that is poised to rebound.
It’s post war and contemporary art.
Sounds crazy, but over 70,000 investors have followed suit since 2019—with Masterworks.
You can invest in shares of artworks featuring Banksy, Basquiat, Picasso, and more.
24 exits later, results speak for themselves: net annualized returns like 14.6%, 17.6%, and 17.8%.*
My subscribers can skip the waitlist.
*Investing involves risk. Past performance is not indicative of future returns. Important Reg A disclosures: masterworks.com/cd.
The Content is for informational purposes only, you should not construe any such information or other material as legal, tax, investment, financial, or other advice.